ARR on NYSE
Armour Residential REIT, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Interest Income (including $0, $0 and $973, respectively with BUCKLER) | $800.4M | $550.9M | $552.9M |
| Net Interest Income | $158.3M | $26.8M | $27.1M |
| Realized loss on sale of available for sale Agency Securities (reclassified from Other comprehensive loss) | $0 | $0 | -$7.5M |
| Gain (Loss) on Agency Securities, trading, net | $514.8M | -$348.6M | -$52.7M |
| Gain on derivatives, net | -$285.7M | $323.5M | $51.7M |
| Total Other Income (Loss) | $219.1M | $12.5M | -$51.5M |
| Management fees | $45.5M | $39.7M | $38.2M |
| Compensation | $3.6M | $4.7M | $4.9M |
| Other Operating | $12.3M | $15.8M | $7.0M |
| Total Expenses | $61.3M | $60.2M | $50.2M |
| Less management fees waived | -$6.6M | -$6.6M | -$6.6M |
| Total Expenses after fees waived | $54.7M | $53.6M | $43.6M |
| Net Income (Loss) | $322.7M | -$14.4M | -$67.9M |
| Dividends on preferred stock | -$12.0M | -$12.0M | -$12.0M |
| Net Income (Loss) available (related) to common stockholders | $310.6M | -$26.4M | -$79.9M |
| Reclassification adjustment for realized loss on sale of available for sale Agency Securities | $0 | $0 | $7.5M |
| Net unrealized gain on available for sale Agency Securities | $0 | $0 | $4.1M |
| Other Comprehensive income | $0 | $0 | $11.5M |
| Comprehensive Income (Loss) | $322.7M | -$14.4M | -$56.4M |
| Comprehensive Income (Loss) available (related) to common stockholders | $310.6M | -$26.4M | -$68.4M |
| Basic (in dollars per share) | $3.31 | -$0.51 | -$1.86 |
| Diluted (in dollars per share) | $3.30 | -$0.51 | -$1.86 |
| Dividends declared per common share (in dollars per share) | $2.88 | $2.88 | $5.00 |
| Basic (in shares) | 93.9M shares | 52.2M shares | 43.1M shares |
| Diluted (in shares) | 94.3M shares | 52.2M shares | 43.1M shares |
| Interest expense | $642.1M | $524.1M | $525.8M |
Every line of the balance sheet in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $63.3M | $68.0M | |
| Cash collateral posted to counterparties | $226.7M | $78.2M | |
| Derivatives, at fair value | $611.5M | $908.1M | |
| Accrued interest receivable | $86.2M | $52.9M | |
| Prepaid and other | $1.7M | $1.4M | |
| Total Assets | $21.0B | $13.5B | |
| Repurchase agreements, net (including $8,426,540 and $4,895,003, respectively with BUCKLER) | $17.9B | $10.7B | |
| Obligations to return securities received as collateral, at fair value | $0 | $493.4M | |
| Cash collateral posted by counterparties | $419.4M | $833.9M | |
| Payable for unsettled purchases | $302.1M | $103.5M | |
| Derivatives, at fair value | $19.3M | $1.3M | |
| Accrued interest payable - U.S. Treasury Securities sold short | $0 | $3.8M | |
| Accounts payable and other accrued expenses | $2.2M | $4.7M | |
| Total Liabilities | $18.7B | $12.2B | |
| Preferred stock, $0.001 par value, 50,000 shares authorized; 7.00% Series C Cumulative Preferred Stock; 7,048 shares and 6,847 shares issued and outstanding ($176,196 and $171,175 aggregate liquidation preference), respectively. | $7.0K | $7.0K | |
| Common stock, $0.001 par value, 175,000 and 125,000 shares authorized; 111,915 shares and 62,412 shares issued and outstanding, respectively. | $112.0K | $62.0K | |
| Additional paid-in capital | $5.4B | $4.6B | |
| Cumulative distributions to stockholders | -$2.7B | -$2.4B | -$2.2B |
| Accumulated net loss | -$518.2M | -$840.9M | |
| Total Stockholders Equity | $2.3B | $1.4B | $1.3B |
| Total Liabilities and Stockholders Equity | $21.0B | $13.5B | |
| Accrued interest payable, repurchase agreements, amounts with BUCKLER | $59.3M | $32.1M | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in shares) | 50.0M shares | 50.0M shares | |
| Preferred stock, shares issued (in shares) | 7.0M shares | 6.8M shares | |
| Preferred stock, shares outstanding (in shares) | 7.0M shares | 6.8M shares | |
| Preferred stock, aggregate liquidation preference | $176.2M | $171.2M | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 175.0M shares | 125.0M shares | |
| Common stock, shares issued (in shares) | 111.9M shares | 62.4M shares | |
| Common stock, shares outstanding (in shares) | 111.9M shares | 62.4M shares |
Every line of the cash flow in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net Income (Loss) | $322.7M | -$14.4M | -$67.9M |
| Net (accretion) amortization of premium (discount) on Agency Securities | $1.9M | -$345.0K | $3.4M |
| Realized loss on sale of Agency Securities, available for sale | $0 | $0 | $7.5M |
| (Gain) Loss on Agency Securities, trading, net | -$514.8M | $348.6M | $52.7M |
| Stock based compensation | $2.1M | $3.2M | $3.2M |
| Increase in accrued interest receivable | -$32.9M | -$5.9M | -$18.5M |
| (Increase) decrease in prepaid and other assets | -$287.0K | -$159.0K | $841.0K |
| Change in derivatives, at fair value | $314.5M | -$34.4M | $99.1M |
| Increase in accrued interest payable- repurchase agreements | $27.2M | $5.6M | $7.4M |
| (Decrease) increase in accrued interest payable- U.S. Treasury Securities sold short | -$3.8M | -$1.2M | $1.6M |
| (Decrease) increase in accounts payable and other accrued expenses | -$2.5M | -$2.0M | $315.0K |
| Net cash and cash equivalents and cash collateral posted to counterparties provided by operating activities | $124.2M | $261.5M | $132.8M |
| Principal repayments of Agency Securities | $1.7B | $1.1B | $803.2M |
| Proceeds from sales of Agency Securities | $1.6B | $4.6B | $6.3B |
| Disbursements on reverse repurchase agreements (including $(1,860,188), $(4,643,450) and $(2,774,490), respectively with BUCKLER) | -$2.3B | -$5.8B | -$2.8B |
| Increase (decrease) in cash collateral posted by counterparties | -$414.4M | -$26.3M | -$103.5M |
| Proceeds from subordinated loan due to BUCKLER | $0 | $0 | $105.0M |
| Net cash and cash equivalents and cash collateral posted to counterparties used in investing activities | -$7.3B | -$1.7B | -$3.0B |
| Issuance of common stock, net of expenses | $874.1M | $265.7M | $450.1M |
| Proceeds from repurchase agreements (including $89,783,916, $59,055,222 and $69,806,936, respectively with BUCKLER) | $157.0B | $105.4B | $119.7B |
| Principal repayments on repurchase agreements (including $(86,699,441), $(58,734,577) and $(68,737,266), respectively with BUCKLER) | -$150.3B | -$104.2B | -$116.9B |
| Common stock dividends paid | -$271.4M | -$150.9M | -$216.2M |
| Common stock repurchased, net | -$19.9M | -$1.3M | -$9.9M |
| Net cash and cash equivalents and cash collateral posted to counterparties provided by financing activities | $7.3B | $1.3B | $3.0B |
| Net increase (decrease) in cash and cash equivalents and cash collateral posted to counterparties | $143.8M | -$112.7M | $140.8M |
| Cash paid during the year for interest | $735.4M | $686.2M | $607.0M |
| Payable for unsettled purchases | -$302.1M | -$103.5M | -$171.5M |
| Net unrealized gain (loss) on available for sale Agency Securities | $0 | $0 | $4.1M |
| Amounts receivable for issuance of preferred stock | $36.0K | $0 | $0 |
| Purchases of agency securities | $9.6B | $7.3B | $10.3B |
| Receipts from reverse repurchase agreements | $2.8B | $5.7B | $3.1B |
Recent filings
- Oct 2, 20264
- Oct 2, 20264
- Oct 1, 20268-K
- Sep 30, 20264
- Sep 24, 20268-K
- Sep 11, 20264
- Sep 11, 20268-K
- Sep 10, 2026144
- Aug 27, 20268-K
- Aug 25, 20264
- Aug 25, 20264
- Aug 25, 20264
- Aug 25, 20264
- Aug 25, 20264
- Aug 25, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10